Van den Berghe N, Verstockt B, Gils A, Sabino J, et al. Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations. J Crohns Colitis 2020 Nov 27. pii: 6007493. doi: 10.1093.
PMID: 33245363